FDA
-
-
-
-
-
-
-
BD launches CentroVena One central venous catheter insertion system
-
-
-
-
-
-
-
BD Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
-
-
-
-
-
-
-
BD receives FDA clearance for rapid COVID-19 test
-
-
-
-
-
-
-
Becton Dickinson (BDX) Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE Scaffold in Breast Implant Revision Surgery
-
-
-
-
-
-
-
SEC: Becton Dickinson (BDX) to Pay $175M for misleading investors
-
-
-
-
-
-
-
Becton Dickinson (BDX) and Quest Diagnostics (DGX) Collaborate to Develop Companion Diagnostics for Cancer, Other Diseases
-
-
-
-
-
-
-
BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore
-
330,659 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

